Stay updated on Zephyrus I Clinical Trial

Sign up to get notified when there's something new on the Zephyrus I Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zephyrus I Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Observed a minor page metadata update: Revision: v3.3.2 added and Revision: v3.3.1 removed; no changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T06:08:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    - Added automatic PubMed publications note and updated the page revision to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-21T02:19:25.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page, which previously described potential delays and operating status; the page now presents the trial details without that disclaimer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-13T22:55:14.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Minor layout changes to the study locations section with no alterations to core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T15:28:31.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Core content updated with government funding status and operating guidance plus a new software version (v3.2.0) replacing the old v3.0.2.
    Difference
    2%
    Check dated 2025-10-02T01:47:17.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Removed major drug-safety and quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), significantly reducing core content about drug quality and safety.
    Difference
    0.2%
    Check dated 2025-09-24T20:29:22.000Z thumbnail image

Stay in the know with updates to Zephyrus I Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zephyrus I Clinical Trial page.